Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-casd-3_15-cv-00408/USCOURTS-casd-3_15-cv-00408-1/pdf.json

Nature of Suit Code: 850
Nature of Suit: Securities, Commodities, Exchange
Cause of Action: 28:1331 Fed. Question

---

1

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF CALIFORNIA

NELDA ZAMIR, Individually and on 

Behalf of All Others Similarly Situated,

Plaintiff,

v.

BRIDGEPOINT EDUCATION, INC., et 

al.,

Defendants.

Case No.: 15-CV-408 JLS (DHB)

ORDER GRANTING DEFENDANTS’ 

MOTION TO DISMISS

(ECF No. 58)

Presently before the Court is Defendants Bridgepoint Education, Inc., Andrew S. 

Clark, and Daniel J. Devine’s (collectively, “Defendants”) Motion to Dismiss Plaintiffs’ 

Second Amended Class Action Complaint (“MTD,” ECF No. 58). Also before the Court 

are Lead Plaintiffs’ Response in Opposition to, (“Opp’n,” ECF No. 61), and Defendants’ 

Reply in Support of, (“Reply,” ECF No. 63), Defendants’ MTD. The Court vacated the 

hearing and took this matter under submission without oral argument pursuant to Civil 

Local Rule 7.1(d)(1). (ECF No. 62.) Having considered the parties’ arguments and the law, 

the Court GRANTS Defendants’ MTD.

/ / /

/ / /

/ / /

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 1 of 21
2

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

BACKGROUND

I. The Defendants

Defendant Bridgepoint provides for-profit higher education through two whollyowned subsidiaries, Ashford University and the University of the Rockies. (Second Am.

Class Action Compl. (“SAC”) ¶¶ 3, 24, ECF No. 57.) Its common stock is publicly traded 

on the New York Stock Exchange. (Id. ¶ 24.)

Defendant Clark is a co-founder of Defendant Bridgepoint, as well as its Chief 

Executive Officer, President, and a director. (Id. ¶ 25.) Defendant Devine served as 

Defendant Bridgepoint’s Chief Financial Officer since January 2004 and its Executive Vice 

President since January 2011, resigning both positions on October 1, 2015. (Id. ¶ 27.) 

II. Factual Background

Defendant Bridgepoint’s primary source of revenue is tuition and related fees. (Id. 

¶ 3.) Without federal financial aid, many of Defendant Bridgepoint’s students would not 

choose to attend Bridgepoint’s institutions, nor could they pay the tuition these institutions 

charge. (Id. ¶ 35.)

In mid-2012, Defendant Bridgepoint experienced technical issues during an annual 

upgrade of its student management system. (Id. ¶ 62.) These technical issues resulted in 

delays in packaging students for financial aid qualification in between financial aid award 

years. (Id. ¶ 63.) As a result, a significant number of students were not packaged prior to 

leaving Defendant Bridgepoint’s institutions and were consequently not eligible for 

financial aid funding. (Id. ¶ 64.) These students were therefore required to pay outstanding 

balances without the assistance of financial aid. (Id.)

On March 12, 2013, Defendant Bridgepoint reported an increase in its bad debt 

expense for the fourth quarter of 2012 and the 2012 fiscal year. (Id. ¶ 97.) Defendant 

Devine explained to investors and analysts on an earnings conference call that Defendant 

Bridgepoint’s technical issues were to blame, but that he did not expect the issue to repeat 

in 2013. (Id. ¶¶ 63, 97.) On May 17, 2013, Defendant Bridgepoint issued an amended Form 

10-K for the 2012 fiscal year to reissue its financial statements. (Id. ¶ 67.) 

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 2 of 21
3

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Despite Defendant Bridgepoint’s assurances to the contrary, the 2012 technical 

issues caused a backlog in packaging financial aid throughout 2013. (Id. ¶¶ 63, 97.) 

Consequently, Defendant Bridgepoint continued to report higher than normal bad debt 

expenses as a percentage of revenues. (Id. ¶¶ 11, 98.) 

On December 11, 2013, the United States Securities and Exchange Commission 

(SEC) contacted Defendant Devine with comments and questions regarding Defendant 

Bridgepoint’s declining enrollments but increased revenue for the 2012 fiscal year. (Id.

¶¶ 47, 65.) The SEC also asked Defendant Devine how Defendant Bridgepoint’s internal 

processing issues with financial aid packages had affected its bad debt percentage. (Id.

¶ 65.) Defendant Devine’s January 10, 2014 response detailed Defendant Bridgepoint’s 

2012 technical issues and the backlog affecting financial aid packaging through 2013. (Id.

¶ 65.) In response to the SEC’s inquiry regarding Defendant Bridgepoint’s determination 

that collectability is reasonably assured, Defendant Devine noted that Defendant 

Bridgepoint “conclude[s its] collectability assessment based on the government’s ability to 

pay as opposed to a student’s ability to pay.” (Id. ¶ 45 (emphasis omitted).) Defendant 

Devine’s response prompted the SEC to ask for additional information on February 12, 

2014, including “why it is appropriate to base your collectability assessment on the 

government’s ability to pay.” (Id. ¶ 48.) 

On March 11, 2014, Defendant Bridgepoint preliminarily announced its fourth 

quarter and 2013 fiscal year financial results in a press release. (Id. ¶ 120.) Later that day, 

Defendants held an earnings call, during which Defendants Clark and Devine fielded 

questions relating to Defendant Bridgepoint’s increased bad debt percentage for the 

quarter. (Id. ¶ 121.) Following this news, the price of Defendant Bridgepoint’s stock fell 

15.73%, or $2.99 per share, closing at $16.02 per share following unusually heavy trading 

volume. (Id. ¶ 122.) 

On May 12, 2014, Defendants announced in a press release attached to a Form 8-K

that Defendant Bridgepoint would be unable to timely file its Form 10-Q for the first 

quarter of 2014 because “[t]he Company is working to quantify the impact of an 

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 3 of 21
4

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

outstanding comment the Company received from the [SEC].” (Id. ¶¶ 36, 124.) Defendants 

also explained that Defendant Bridgepoint was evaluating whether to restate its financial 

results for the periods from January 1, 2011 through December 31, 2013. (Id.) Defendants 

Clark and Devine held an earnings conference call later that day, during which Defendant 

Devine admitted that Defendant Bridgepoint’s prior revenue recognition policy was 

incorrect. (Id. ¶ 125.) Specifically, Defendant Devine explained that 

[u]nder previous revenue recognition, revenues recognized subsequent to a

student losing financial aid eligibility, and ultimately not collected, were

included in our bad debt expense. Going forward, our policy will exclude

these revenues and will result in a corresponding decrease in our bad debt

expense that will be realized over subsequent quarters.

(Id. ¶ 37.) Consequently, the price of Defendant Bridgepoint’s shares declined nearly 9%, 

closing at $14.51 per share after unusually heavy trading volume. (Id. ¶ 127.)

The following day, Defendant Devine filed a notification of late filing for the first 

quarter of 2014 on Form 12b-25 with the SEC. (Id. ¶ 126.) This resulted in an additional 

decline of 3.17% in Defendant Bridgepoint’s share price, which closed at $14.05 per share. 

(Id. ¶ 127.)

On May 30, 2014, Defendants announced that they were restating Defendant 

Bridgepoint’s financial results for the fiscal year ending December 31, 2013 and each of 

the three quarterly financial results during the year, as well as revising the financial 

statements for the fiscal years ending in December 31, 2012 and 2011. (Id. ¶¶ 13, 128–29.) 

On June 2, 2014, the first trading day following the press release, the price of Defendant 

Bridgepoint’s shares declined by 1.31%, or $0.17 per share, closing at $12.82. (Id. ¶¶ 14, 

130.) Defendant Bridgepoint issued its restated 2013 financials on August 4, 2014. (Id.

¶¶ 4, 38.)

/ / /

/ / /

/ / /

/ / /

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 4 of 21
5

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

As a result of the restatement, Defendant Bridgepoint saw a decrease in revenues, 

but a corresponding increase in net income and decrease in its bad debt expense:

Financial 

Period

Original 

Revenue 

(millions)

Restated 

Revenue 

(millions)

Difference 

in Revenue

Original 

Bad Debt 

Expense 

(millions)

Restated 

Bad Debt 

Expense 

(millions)

Original 

Bad 

Debt/

Revenue

Restated 

Bad 

Debt/

Revenue

Original 

Net 

Income 

(millions)

Restated 

Net 

Income/

Loss

(millions)

Difference 

in Net 

Income/

Loss

FY 2012 $968.2 $943.4 (2.6%) $73.7 $52.8 7.6% 5.6% $123.4 $121.1 (1.9%)

1Q 2013 $222.0 $213.0 (4.1%) $18.3 $13.0 8.2% 6.1% $27.0 $24.7 (8.5%)

2Q 2013 $197.6 $193.4 (2.1%) $18.6 $11.4 9.4% 5.9% $10.4 $12.1 16.3%

3Q 2013 $185.6 $182.8 (1.5%) $16.8 $7.3 9.0% 4.0% $10.1 $14.2 40.6%

4Q 2013 $163.5 $162.2 (0.8%) $18.7 $15.4 11.4% 9.5% ($6.5) ($5.1) (21.5%)

FY 2013 $768.6 $751.4 (2.2%) $72.3 $47.1 9.4% 6.3% $41.0 $45.9 12.0%

(Id. ¶ 43; MTD Mem. 6, ECF No. 58-1; Manolova Decl. Ex. E at 32–33, ECF No. 28-2 at 

39–40.)1

On July 25, 2014, Defendant Bridgepoint disclosed that the SEC was investigating 

its accounting practices, including revenue recognition and receivables. (Id. ¶ 134.) The 

SEC also issued a subpoena for the revised and restated time periods, and documents and 

information dating back to July 1, 2009 to the present. (Id.) On July 12, 2016, via a Form 

8-K filed with the SEC, Defendant Bridgepoint announced that the Department of 

Education would commence a review of Ashford’s administration of federal student 

financial aid programs for certain students identified in the 2009–2012 calendar year. (Id.

¶ 136.) In this same Form 8-K, Defendant Bridgepoint also announced that the U.S. 

Department of Justice was conducting an “investigation concerning allegations that the 

Company may have misstated Title IV refund revenue or overstated revenue associated 

with private secondary loan programs and thereby misrepresented its compliance with the 

90/10 rule of the Higher Education Act.” (Id. ¶ 137.)

/ / /

/ / /

 

1 This table is based on Plaintiffs’ allegations in addition to documents submitted as Exhibits to the 

Manolova Declaration in Defendants’ first Motion to Dismiss and Request for Judicial Notice, (ECF No. 

28), which the Court granted in its entirety, (see ECF No. 53).

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 5 of 21
6

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

III. Procedural Background

Lead Plaintiff Zamir filed an initial complaint on February 24, 2015, alleging two 

causes of action for violation of Section 10(b) of the Exchange Act and Rule 10b-5 and 

violation of Section 20(a) of the Exchange Act. (See generally ECF No. 1.) Lead Plaintiffs 

moved for appointment as lead plaintiffs and approval of choice of counsel on April 27, 

2015. (See ECF No. 3.) Because the motion was unopposed, (see ECF No. 13), the Court 

granted Lead Plaintiffs’ motion, (see ECF No. 14).

On September 18, 2015, Lead Plaintiffs filed the AC, asserting the same causes of 

action as in the original complaint. (See ECF No. 17.) Several Defendants filed motions to 

dismiss on November 24, 2015, (see ECF Nos. 28, 30), and on January 11, 2016, Lead 

Plaintiffs filed a Motion to Strike, (see ECF No. 37). The Court granted Defendants’ 

motions to dismiss, and denied Lead Plaintiffs’ Motion to Strike. (“First MTD Order,” ECF 

No. 53.) Thereafter Lead Plaintiffs dismissed several named Defendants. (ECF Nos. 56, 

59.) Lead Plaintiffs filed their SAC on September 9, 2016. (ECF No. 57.) Defendants filed 

the instant Motion to Dismiss on October 24, 2016.

MOTION TO DISMISS

I. Legal Standard

Federal Rule of Civil Procedure 12(b)(6) permits a party to raise by motion the 

defense that the complaint “fail[s] to state a claim upon which relief can be granted,” 

generally referred to as a motion to dismiss. The Court evaluates whether a complaint states 

a cognizable legal theory and sufficient facts in light of Federal Rule of Civil Procedure 

8(a), which requires a “short and plain statement of the claim showing that the pleader is 

entitled to relief.” Although Rule 8 “does not require ‘detailed factual allegations,’ . . . it 

[does] demand more than an unadorned, the-defendant-unlawfully-harmed-me 

accusation.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. 

Twombly, 550 U.S. 544, 555 (2007)). In other words, “a plaintiff’s obligation to provide 

the ‘grounds’ of his ‘entitle[ment] to relief’ requires more than labels and conclusions, and 

a formulaic recitation of the elements of a cause of action will not do.” Twombly, 550 U.S. 

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 6 of 21
7

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

at 555 (citing Papasan v. Allain, 478 U.S. 265, 286 (1986)). A complaint will not suffice 

“if it tenders ‘naked assertion[s]’ devoid of ‘further factual enhancement.’” Iqbal, 556 U.S. 

at 677 (citing Twombly, 550 U.S. at 557).

In order to survive a motion to dismiss, “a complaint must contain sufficient factual 

matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Id. (quoting 

Twombly, 550 U.S. at 570); see also Fed. R. Civ. P. 12(b)(6). A claim is facially plausible 

when the facts pled “allow the court to draw the reasonable inference that the defendant is 

liable for the misconduct alleged.” Iqbal, 556 U.S. at 677 (citing Twombly, 550 U.S. at 

556). That is not to say that the claim must be probable, but there must be “more than a 

sheer possibility that a defendant has acted unlawfully.” Id. Facts “‘merely consistent with’ 

a defendant’s liability” fall short of a plausible entitlement to relief. Id. (quoting Twombly, 

550 U.S. at 557). Further, the Court need not accept as true “legal conclusions” contained 

in the complaint. Id. This review requires context-specific analysis involving the Court’s 

“judicial experience and common sense.” Id. at 678 (citation omitted). “[W]here the wellpleaded facts do not permit the court to infer more than the mere possibility of misconduct, 

the complaint has alleged—but it has not ‘show[n]’—‘that the pleader is entitled to relief.’” 

Id.

Where a complaint does not survive 12(b)(6) analysis, the Court will grant leave to 

amend unless it determines that no modified contention “consistent with the challenged 

pleading . . . [will] cure the deficiency.” DeSoto v. Yellow Freight Sys., Inc., 957 F.2d 655,

658 (9th Cir. 1992) (quoting Schriber Distrib. Co. v. Serv-Well Furniture Co., 806 F.2d 

1393, 1401 (9th Cir. 1986)).

“Claims brought under Rule 10b-5 . . . must meet Federal Rule of Civil Procedure 

9(b)’s particularity requirement that ‘[i]n all averments of fraud or mistake, the 

circumstances constituting fraud or mistake shall be stated with particularity.’” In re Dura 

Pharm., Inc. Sec. Litig., 452 F. Supp. 2d 1005, 1016 (S.D. Cal. 2006) (alteration in original) 

(quoting Fed. R. Civ. P. 9(b)) (citing In re Daou Sys., Inc. Sec. Litig., 411 F.3d 1006, 1014 

(9th Cir. 2005), cert. denied, 546 U.S. 1172 (2006); Yourish v. Cal. Amplifier, 191 F.3d 

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 7 of 21
8

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

983, 993 (9th Cir. 1999)). “In addition, in 1995, Congress enacted the Private Securities 

Litigation Record Act of 1995 (PSLRA) and altered the pleading requirements in private 

securities fraud litigation by requiring a complaint plead with particularity both falsity and 

scienter.” Id. at 1016–17 (quoting Daou Sys., 411 F.3d at 1014) (internal quotation marks 

omitted). 

II. Analysis

As before, Lead Plaintiffs assert two causes of action: (1) violation of Section 10(b) 

of the Exchange Act and Rule 10b-5 against all Defendants, and (2) violation of Section 

20(a) of the Exchange Act against Defendants Clark and Devine (collectively, the 

“Individual Defendants”). (See generally SAC, ECF No. 57.) Defendants ask the Court to 

dismiss Lead Plaintiffs’ SAC with prejudice. (See MTD Mem. 18, ECF No. 58-1.)

A. Section 10(b) and Rule 10b-5

“Section 10(b) of the Securities Exchange Act of 1934 forbids (1) the ‘use or 

employ[ment] . . . of any . . . deceptive device,’ (2) ‘in connection with the purchase or sale 

of any security,’ and (3) ‘in contravention of’ Securities and Exchange Commission ‘rules 

and regulations.’” Dura Pharm., Inc. v. Broudo, 544 U.S. 336, 341 (2005) (quoting 15 

U.S.C. § 78j(b)). “Commission Rule 10b-5 forbids, among other things, the making of any 

‘untrue statement of a material fact’ or the omission of any material fact ‘necessary in order 

to make the statements made . . . not misleading.’” Id. (quoting 17 CFR § 240.10b-5 

(2004)). “The basic elements of a Rule 10b-5 claim, therefore, are: (1) a material 

misrepresentation or omission of fact, (2) scienter, (3) a connection with the purchase or 

sale of a security, (4) transaction and loss causation, and (5) economic loss.” Daou Sys., 

411 F.3d at 1014 (citing Dura Pharms., 544 U.S. at 341–42). Defendants challenge the 

adequacy of Lead Plaintiffs’ allegations concerning only the second and fourth elements. 

(See generally MTD Mem., ECF No. 58-1; see also Opp’n 1, ECF No. 61; Reply 4–9, ECF 

No. 63.)

/ / /

/ / /

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 8 of 21
9

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1. Scienter

A private securities plaintiff must “state with particularity facts giving rise to a strong 

inference that the defendant acted with the required state of mind.” 15 U.S.C. § 78u-4(b)(2). 

The “required state of mind” is “scienter,” i.e., “a mental state embracing intent to deceive, 

manipulate, or defraud.” Ernst & Ernst v. Hochfelder, 425 U.S. 185, 193 n.12 (1976); In 

re Silicon Graphics Inc. Sec. Litig., 183 F.3d 970, 975 (9th Cir. 1999), abrogated on other 

grounds by S. Ferry LP, No. 2 v. Killinger, 542 F.3d 776 (9th Cir. 2008); In re Peerless 

Sys., Corp. Sec. Litig., 182 F. Supp. 2d 982, 987–88 (S.D. Cal. 2002). “[T]he PSLRA 

requires plaintiffs to plead, at a minimum, particular facts giving rise to a strong inference 

of deliberate or conscious recklessness.” Silicon Graphics, 183 F.3d at 979; In re Wet Seal, 

Inc. Sec. Litig., 518 F. Supp. 2d 1148, 1157 (C.D. Cal. 2007). Recklessness amounts to 

“‘an extreme departure from the standards of ordinary care, and . . . presents a danger of 

misleading buyers and sellers that is either known to the defendant or is so obvious that the 

actor must have been aware of it.’” DSAM Global Value Fund v. Altris Software, Inc., 288 

F.3d 385, 389 (9th Cir. 2002) (quoting Hollinger v. Titan Cap. Corp., 914 F.2d 1564, 1569 

(9th Cir. 1990)). To satisfy this pleading requirement, “the complaint must contain 

allegations of specific ‘contemporaneous statements or conditions’ that demonstrate the 

intentional or the deliberately reckless false or misleading nature of the statements when 

made.” Ronconi v. Larkin, 253 F.3d 423, 432 (9th Cir. 2001); In re Levi Strauss & Co. Sec. 

Litig., 527 F. Supp. 2d 965, 988 (N.D. Cal. 2007). The Court must consider competing 

inferences that could be drawn in favor of plaintiffs or defendants and determine whether 

plaintiffs have pled a “strong inference” of scienter which is “cogent and at least as 

compelling as any opposing inference of nonfraudulent intent.” Tellabs, Inc. v. Makor 

Issues & Rights, Ltd., 551 U.S. 308, 314 (2007). 

/ / /

/ / /

/ / /

/ / /

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 9 of 21
10

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Defendants argue that Lead Plaintiffs once again fail to adequately plead scienter.

(MTD Mem. 4–13, ECF No. 58-1.) The Court agrees.2

a. GAAP3 Violations

Lead Plaintiffs structure their opposition by responding to the directive of the 

Court’s First MTD Order. (See generally Opp’n, ECF No. 61.) Specifically, the Court 

concluded that

[a]t the very least, the plaintiff must present facts demonstrating that the 

defendant was aware of the relevant GAAP principle and that this defendant 

knew how that princip[le] was being interpreted. The plaintiff must then plead 

facts explaining how the defendant’s incorrect interpretation was so 

unreasonable or obviously wrong that it should give rise to an inference of 

deliberate wrongdoing.

(First MTD Order 13–14 (quoting In re Medicis Pharm. Corp. Sec. Litig., No. CV-08-

1821-PHX-GMS, 2010 WL 3154863, at *5 (D. Ariz. Aug. 9, 2010) (citing Medicis, 689 F. 

Supp. 2d at 1204)).) Lead Plaintiffs argue that their allegations in the SAC are sufficient to 

demonstrate that Defendants were deliberately reckless. (Opp’n 7, ECF No. 61.) 

Specifically, Lead Plaintiffs argue that at least three different events “necessitated 

Defendants’ review, and thus, awareness of Defendant Bridgepoint’s collectability 

assurance assessment. Based on the facts alleged in the SAC, Defendants’ failure to review 

this policy during or after any of these three events amounts to deliberate recklessness.” 

(Id.)

First, Lead Plaintiffs argue that 

Defendants Devine and Clark were made aware that: (1) under GAAP and

SEC guidance, revenue cannot be recognized until collectibility is reasonably 

 

2 Although the Court addresses a number of Lead Plaintiffs’ allegations individually, “it is cognizant of 

the duty to conduct a holistic analysis of Plaintiffs’ scienter allegations. The flaws of the various 

allegations must be exposed as part of the Court’s holistic analysis.” Westley v. Oclaro, Inc., No. C-11-

2448 EMC, 2013 WL 2384244, at *5 (N.D. Cal. May 30, 2013). 

3 Generally Accepted Accounting Principles (“GAAP”). See, e.g., Metzler Inv. GMBH v. Corinthian 

Colls., Inc., 540 F.3d 1049, 1056 (9th Cir. 2008).

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 10 of

 21
11

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

assured (see ¶41); (2) Bridgepoint undertook an assessment of whether the 

collectibility of its revenue was reasonably assured (¶45) and (3) 

Bridgepoint’s collectibility assurance assessment did not take into 

consideration a student’s ability to pay (see ¶45) by, at the latest, January 10,

2014, when Defendant Devine responded to an earlier SEC comment.

(Id. at 7.) Thus, “Defendants Clark and Devine were put on notice when the SEC raised 

the issue.” (Id. at 7–8.) 

Second, Lead Plaintiffs argue that on an earnings call on March 12, 2013, 

Defendants Clark and Devine, by “assuring investors and analysts that they knew why the 

Bad Debt Percentage increased, [they] implicitly admitted that they knew how Bridgepoint 

accounted for both revenues and bad debt expenses . . . [which] in turn necessitated an 

understanding of Bridgepoint’s revenue recognition policy and the Company’s 

collectability assurance as part of that policy.” (Id. at 8.)

Third, Lead Plaintiffs similarly argue that Defendant Devine’s announcement 

accompanying their amended Form 10-K that Defendant Bridgepoint would, among other 

things, focus on “improvements in the accounting process” would have “necessitated a 

review of Bridgepoint’s revenue recognition policy and the Company’s collectability 

assurance assessment.” (Id. at 9.)

As to the first “event,” the Court agrees with Defendants that “being ‘put on notice’ 

in this context simply means an awareness that there was an issue, with the January 10, 

2014 letter to the SEC articulating Bridgepoint’s position on that issue.” (Reply 5, ECF 

No. 63.) This does not establish the requisite scienter.

That said, the Court is convinced that the other two events plausibly demonstrate 

that Defendant Devine was “aware of the relevant GAAP principle and that this defendant 

knew how that princip[le] was being interpreted.” In re Medicis Pharm. Corp. Sec. Litig., 

2010 WL 3154863, at *5. Specifically, these events strongly suggest that Defendant 

Devine’s admissions and remediation plan demonstrated an understanding of the 

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 11 of

 21
12

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

underlying GAAP principle and how it was applied by Defendant Bridgepoint.4 See, e.g., 

id. at *6 (“Plaintiffs allege that Medicis executives, in particular Peterson and Prygocki, 

emphasized the importance of the Company’s return methodology and stated that the 

Company was not ‘booking revenue in advance of future quarters.’”); cf. Reese v. Malone, 

747 F.3d 557, 571 (9th Cir. 2014) (“In the wake of a crisis that has the potential to repeat 

itself, Johnson had every reason to review the results of BP-Alaska’s corrosion monitoring 

to understand what happened, as well as to assess the possibility of future leaks in similar 

pipelines. Evidence of high levels of corrosion would be central to this inquiry.”). 

However, the Court agrees with Defendants that Lead Plaintiffs do not identify any specific 

allegations against Defendant Clark. (See Reply 6 n.7, ECF No. 63.)

But awareness is not enough. Even if these three “events” adequately demonstrated 

that Defendants were aware of a particular GAAP principle and how it was being 

interpreted, Lead Plaintiffs must also plead facts explaining how Defendants’ “incorrect 

interpretation was so unreasonable or obviously wrong that it should give rise to an 

inference of deliberate wrongdoing.” In re Medicis Pharm. Corp. Sec. Litig., 2010 WL 

3154863, at *5. Lead Plaintiffs fail to do so.

Lead Plaintiffs argue that (1) “Bridgepoint’s collectiblity assurance assessment was 

unreasonable and obviously wrong on its face” and “something that a non-accountant, like 

Defendant Clark, could understand,” (Opp’n 10, ECF No. 61); (2) Defendants knew that 

independent paying students were less likely to pay tuition, (id. at 11); (3) anyone working 

in the for-profit education sector would have known that these students would have trouble 

paying tuition without financial aid, (id.); (4) Defendants were put on notice that the 

government would not be paying tuition for a significant number of students, (id. at 12);

and (5) Defendants knew that a significant number of students left Bridgepoint mid-course, 

including new allegations of a confidential witness explaining, among other things, that the 

 

4 Defendants appear to concede as much. See, e.g., (Reply 6, ECF No. 63 (“While obviously at least (CFO) 

Devine knew Bridgepoint’s revenue recognition policy as it pertained to the independent students . . . .”).) 

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 12 of

 21
13

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Individual Defendants looked at numbers used to assess when a student was likely to leave 

Bridgepoint, (id. at 12).

As before, the Court concludes that these allegations fail to give rise to an 

inference—much less a strong inference—of deliberate wrongdoing. The “GAAP is not 

the lucid or encyclopedic set of pre-existing rules that [Lead Plaintiffs] might perceive it 

to be.” Shalala v. Guernsey Mem’l Hosp., 514 U.S. 87, 101 (1995). “There are 19 different 

GAAP sources, any number of which might present conflicting treatments of a particular 

accounting question.” Id. (citing Robert S. Kay & D. Gerald Searfoss, Handbook of 

Accounting and Auditing: 1994 Update With Cumulative Index, ch. 5, at 6–7 (2d ed. 

1993)). Consequently, GAAP “tolerate a range of ‘reasonable’ treatments, leaving the 

choice among alternatives to management.” Thor Power Tool Co. v. Comm’r of Internal

Revenue, 439 U.S. 522, 544 (1979). The Ninth Circuit therefore recognizes that “the mere 

publication of inaccurate accounting figures, or a failure to follow GAAP, without more, 

does not establish scienter.” DSAM, 288 F.3d at 390 (quoting In re Software Toolworks, 

Inc., 50 F.3d 615, 627 (9th Cir. 1994)). Violations of GAAP, “even significant ones or ones 

requiring large or multiple restatements, must be augmented by other specific allegations 

that defendants possessed the requisite mental state.” In re Int’l Rectifier Corp. Sec. Litig., 

No. CV07-02544-JFWVBKX, 2008 WL 4555794, at *13 (C.D. Cal. May 23, 2008)

(collecting cases). 

Lead Plaintiffs’ identified allegations5 do not alter the Court’s previous analysis. In 

 

5 This includes Lead Plaintiffs’ reliance on a confidential witness (“CW1”) who stated, for example, that 

Bridgepoint was tracking student retention and that these data were available to Defendants Clark and 

Devine. (See, e.g., SAC ¶ 60, ECF No. 57.) CW1 also “commented that it felt kind of cool to know that 

the CEO and CFO were looking at the numbers [he/she] provided.” (Id.) But “corporate management’s 

general awareness of the day-to-day workings of the company’s business does not establish scienter—at 

least absent some additional allegation of specific information conveyed to management and related to 

fraud.” Metzler, 540 F.3d at 1068 (emphasis added). See also In re Maxwell Techs., Inc. Sec. Litig., 18 F. 

Supp. 3d 1023, 1041 (S.D. Cal. 2014) (holding that “[a]lthough Plaintiff has alleged that the individual 

defendants attended sales-related meetings and had access to sales reports, this does not support the 

inference that the individual defendants must have known about the accounting misconduct” (emphases 

added)). Lead Plaintiffs fail to provide these additional allegations.

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 13 of

 21
14

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

fact, the crux of Lead Plaintiffs’ GAAP identified allegations remains the same from the 

AC: Defendants “knew or recklessly disregarded the necessity to reassess whether 

collectability was reasonably assured on a student-by-student basis when recognizing 

revenue subsequent to a student’s initial enrollment with Bridgepoint’s institutions upon a 

change in facts or circumstances that would affect a student’s ability to pay, in violation of 

GAAP.” (AC ¶ 90, ECF No. 17; see also SAC ¶ 5, ECF No. 57 (“Defendants knew or 

recklessly disregarded that the collectibility of this revenue was not reasonably assured.”).) 

As before, “[t]he [S]AC does not allege that [Bridgepoint]’s external auditors 

counseled against the practice or that [any of the Individual Defendants] admitted or was 

aware it was improper.” Metzler, 540 F.3d at 1069.

6

Instead, Lead Plaintiffs again 

emphasize the obviousness of the violations. (Compare Opp’n 10, ECF No. 61, with MTD 

Opp’n 20–21, ECF No. 36.) Specifically, Lead Plaintiffs allege that

Defendants were at a minimum deliberately reckless in basing the assurance

of collectibility of its revenues on the government, military, or corporations 

when Bridgepoint did not ultimately derive 100% of its revenue from these 

parties. Additionally, during the Class Period, when Defendants knew key 

facts indicating that significant amount of revenue due from students was not 

reasonably assured to be collectible, it was at minimum, extremely reckless 

for Defendants to continue to base their revenue recognition collectibility 

assurance off of the government’s ability to pay.

(SAC ¶ 75, ECF No. 57.)

This is again insufficient. “A plaintiff . . . cannot merely point at a GAAP principle 

and contend that a correct interpretation was simple or obvious.” Medicis Pharm., 2010 

WL 3154863, at *5. And, as in Metzler, “[a]lthough the [S]AC does draw its own legal 

conclusion that the practice was improper, . . . the [S]AC’s factual allegations point only 

 

6 The Court does not, as Lead Plaintiffs caution, “adopt a rule that in all accounting cases where a clean 

audit opinion is issued, the plaintiff must allege that the defendants withheld information from the auditor 

or that the auditor committed fraud or serious error.” (Opp’n 16, ECF No. 61.) And the Court agrees with 

Lead Plaintiffs that an audit opinion “does not, standing alone, negate any otherwise compelling inference 

of scienter plaintiffs’ pleading raises.” Okla. Firefighters Pension & Ret. Sys. v. IXIA, 50 F. Supp. 3d 

1328, 1365 n.183 (C.D. Cal. 2014) (emphasis added).

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 14 of

 21
15

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

to disagreement and questioning . . . about the practice.” See 540 F.3d at 1069. Furthermore, 

Defendants again persuasively argue that Lead Plaintiffs fail to plausibly allege that Mr. 

Clark “had any knowledge of, or involvement with, the accounting for the independent 

paying students,” (MTD Mem. 8, ECF No. 58-1), much less that Mr. Clark, a nonaccountant, “would have an informed opinion as to whether treating the independent 

paying students as presenting a revenue recognition issue, versus a bad debt issue, was the 

only correct decision under GAAP,” (id.). Lead Plaintiffs’ allegations against Mr. Devine 

fare no better, since, as before, the SAC details a back-and-forth over the appropriate 

accounting treatment between Mr. Devine and the SEC, (See SAC ¶¶ 45–48, 63–65, ECF 

No. 57), plausibly “suggesting that there was room for reasonable people to disagree over 

this issue,” (MTD Mem. 9, ECF No. 58-1).7 See In re Nuko Info. Sys. Sec. Litig., 199 F.R.D. 

338, 344 (N.D. Cal. 2000) (“[I]t is well established that GAAP violations, without more, 

do not establish scienter, even if those GAAP violations were deliberate.” (citing In re 

Worlds of Wonder Sec. Litig., 35 F.3d 1407, 1426 (9th Cir.1994))); In re REMEC Inc. Sec. 

Litig., 702 F. Supp. 2d 1202, 1243 (S.D. Cal. 2010) (“[E]ven deliberate GAAP violations 

do not by themselves establish scienter.” (internal citation omitted)). As before, Lead 

Plaintiffs’ allegations concerning the GAAP violations do not lead to an inference of 

scienter as compelling as the inference raised by Defendants. (See MTD Mem. 10, ECF 

No. 58-1 (“It is not as through Bridgepoint completely ignored the fact that the independent 

paying students were less likely to fulfill their contractual obligations to Bridgepoint—

Bridgepoint just dealt with that issue by raising its levels of bad debt. Although a 

restatement involves an admission that the accounting treatment was incorrect, in the 

abstract treating the independent paying students as presenting a bad debt issue does not 

seem so odd or ignorant that the only plausible answer is fraud.”).)

 

7 The Court agrees with Lead Plaintiffs that, compared to the AC, the SAC compresses the dialogue 

between the SEC and Defendant Devine. But the SAC still alleges a conversation between the SEC and 

Defendant Devine regarding Devine’s explanation as to “how the financial aid processing issue affected 

the Bad Debt Percentage.” (SAC ¶ 65, ECF No. 57.) 

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 15 of

 21
16

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

With regard to restatements, “[i]n general, the mere publication of a restatement is 

not enough to create a strong inference of scienter.” Zucco Partners, LLC v. Digimarc 

Corp., 552 F.3d 981, 1000 (9th Cir. 2009), as amended (Feb. 10, 2009). The Ninth Circuit 

does recognize two “narrow” exceptions to this general rule, however. Id. (citing S. Ferry, 

542 F.3d at 785). 

The first exception permits general allegations about 

“management’s role in a corporate structure and the importance 

of the corporate information about which management made 

false or misleading statements” to create a strong inference of 

scienter when these allegations are buttressed with “detailed and 

specific allegations about management’s exposure to factual 

information within the company.”

Id. (quoting S. Ferry, 542 F.3d at 785). “The second exception . . . permits an inference of 

scienter where the information misrepresented is readily apparent to the defendant 

corporation’s senior management,” i.e., “where the falsity is patently obvious—where the 

facts [are] prominent enough that it would be absurd to suggest that top management was 

unaware of them.” Id. at 1001 (quoting Berson v. Applied Signal Tech., Inc., 527 F.3d 982, 

989 (9th Cir. 2008)) (internal quotation marks omitted). 

Lead Plaintiffs’ allegations satisfy neither of these exceptions for many of the same 

reasons discussed above. Moreover, the restated revenue for fiscal year 2013 differed by 

only 2.2%. (See SAC ¶ 43, ECF No. 17; see also MTD Mem. 7, ECF No. 58-1.) “When 

restatements have been considered evidence of scienter, the restatements were of 

considerably greater magnitude than those here.” See In re Aspeon, Inc. Sec. Litig., 168 F. 

App’x 836, 839 (9th Cir. 2006) (affirming district court’s dismissal of § 10(b) claim where 

restatement “only demonstrated a revenue reduction of 1.57%” and therefore failed to “give 

rise to a strong inference the original statements were issued with deliberate or conscious 

recklessness”).

/ / /

/ / /

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 16 of

 21
17

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Accordingly, Lead Plaintiffs’ allegations concerning Defendants’ GAAP violations 

and restatement of Defendant Bridgepoint’s financials fail to establish a strong inference 

of scienter.

b. Sarbanes-Oxley Certifications and Internal Control Deficiencies

Defendants argue that Lead Plaintiffs’ allegations with respect to the contents of the 

Individual Defendants’ Sarbanes-Oxley certifications in the SAC are largely identical to 

those alleged in the AC, (MTD Mem. 11, ECF No. 58-1 (comparing SAC ¶¶ 113–15, with 

AC ¶¶ 109–111)), which the Court found insufficient in its previous Order. (First MTD 

Order 19, ECF No. 53.) Lead Plaintiffs concede that these certifications alone do not add 

to the inference of scienter, but “may provide additional evidence of scienter if the 

certifications were false and misleading and the defendant knew that, or was deliberately 

reckless in issuing the certifications.” (Opp’n 13, ECF No. 61 (citing Stocke v. Shuffle 

Master, Inc., 615 F. Supp. 2d 1180, 1190 (D. Nev. 2009)).)

With respect to the false Sarbanes-Oxley certifications, “Sarbanes-Oxley 

certifications are not sufficient, without more, to raise a strong inference of scienter.” Zucco 

Partners, 552 F.3d at 1004 (quoting Glazer Capital Mgmt., LP v. Magistri, 549 F.3d 736, 

747–48 (9th Cir. 2008)). Moreover, “required certifications under Sarbanes-Oxley . . . add 

nothing substantial to the scienter calculus . . . and do not make . . . otherwise insufficient 

allegations more compelling by their presence in the same complaint.” Id. at 1003–04. As 

before, the Court gives no weight to Lead Plaintiffs’ allegations concerning Defendants’ 

false Sarbanes-Oxley certifications either individually or in the Court’s holistic analysis.

See infra Part II.A.1.e.

c. Government Investigations

Lead Plaintiffs argue that the “investigations being conducted by the SEC, 

Department of Education, and Department of Justice all further support an inference of 

scienter.” (Opp’n 14, ECF No. 61.) The Court therefore considers Lead Plaintiffs’ 

allegations concerning these government investigations as part of the Court’s holistic 

analysis. See infra Part II.A.1.e.

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 17 of

 21
18

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

d. Holistic Analysis

Although none of Lead Plaintiffs’ individual allegations concerning Defendants’ 

scienter is availing, the Court must also “review ‘all the allegations holistically.’” See 

Matrixx Initiatives, Inc. v. Siracusano, 563 U.S. 27, 48 (2011) (citing Tellabs, 551 U.S. at 

326). “The inquiry . . . is whether all of the facts alleged, taken collectively, give rise to a 

strong inference of scienter.” Tellabs, 551 U.S. at 322–23 (emphasis in original).

Even viewed holistically, however, Lead Plaintiffs’ allegations again do not give rise 

to a strong inference of scienter that is at least as compelling as an inference of 

nonfraudulent conduct. And the Court notes that it conducts its holistic analysis this time 

around without Lead Plaintiffs’ allegations of insider trading, (see First MTD Order 16–

19, ECF No. 53), which Lead Plaintiffs removed from their SAC, (see generally SAC, ECF 

No. 57). As before, the SAC does not support an inference of scienter “that is greater than 

the sum of its parts.” Rubke v. Capitol Bancorp Ltd, 551 F.3d 1156, 1165 (9th Cir. 2009) 

(citing S. Ferry, 542 F.3d at 784; Metzler, 540 F.3d at 1049). The Court therefore

GRANTS Defendants’ MTD (ECF No. 58) and DISMISSES WITHOUT PREJUDICE

Lead Plaintiffs’ first cause of action.

2. Loss Causation

To demonstrate loss causation, a plaintiff must allege “a causal connection between 

the material misrepresentation and the loss.” 15 U.S.C. § 78u-4(b)(4); Dura Pharm., Inc. 

v. Broudo, 544 U.S. 336, 342 (2005). In other words, “the complaint must allege that the 

practices that the plaintiff contends are fraudulent were revealed to the market and caused 

the resulting losses.” Metzler, 540 F.3d at 1061. A corrective disclosure must reveal some 

aspect of the alleged fraud to the market. See Lentell v. Merrill Lynch & Co., 396 F.3d 161, 

175 (2d Cir. 2005). Additionally, a plaintiff’s allegations must reveal that “the defendant’s 

‘share price fell significantly after the truth became known.’” Metzler, 540 F.3d at 1062 

(quoting Dura Pharm., 544 U.S. at 347). The Ninth Circuit has recently clarified that the 

plaintiff must only allege “facts that, if taken as true, plausibly establish loss causation,” In 

re Gilead Scis. Sec. Litig., 536 F.3d 1049, 1057 (9th Cir. 2008), “suggesting that loss 

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 18 of

 21
19

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

causation is a fact-intensive inquiry better suited for determination at trial than at the 

pleading stage,” Rudolph v. UTStarcom, No. C 07-04578 SI, 2008 WL 4002855, at *4 

(N.D. Cal. Aug. 21, 2008) (citing McCabe v. Ernst & Young, LLP, 494 F.3d 418, 427 n.4 

(3rd Cir. 2007); Emergent Capital Inv. Mgmt., LLC v. Stonepath Grp., Inc., 343 F.3d 189, 

197 (2d Cir. 2003)). Rule 9(b)’s heightened pleading standard applies to allegations of loss 

causation. Or. Pub. Emps. Ret. Fund v. Apollo Grp. Inc., 774 F.3d 598, 605 (9th Cir. 2014).

As before, Lead Plaintiffs point to the following partial corrective disclosures to 

argue that the alleged fraud was revealed to the market: (1) the March 11, 2014 press 

release preliminarily announcing Defendant Bridgepoint’s fourth quarter and 2013 fiscal 

year results and subsequent earnings call, (SAC ¶¶ 12, 120, 123, ECF No. 57); (2) the May 

12, 2014 press release disclosing, among other things, the SEC’s inquiry and Defendant 

Bridgepoint’s evaluation of whether a restatement of its 2011 through 2013 financial 

results was necessary, as well as the earnings conference call held that same day, (id.

¶¶ 124–127); and (3) the May 30, 2014 8-K revealing Defendant Bridgepoint’s conclusion 

that there were material misstatements of revenue and bad debt expense as well as material 

weaknesses over financial reporting, and also providing an estimate of the restated revenue 

and expenses for the 2013 fiscal year, (id. ¶¶ 128–29). (See Opp’n 18–19, ECF No. 61.)

Defendants “are cognizant of the Court’s Order finding Plaintiffs’ prior loss causation 

allegations to be sufficient,” but argue that these three partial disclosure dates fail to 

adequately plead loss causation. (Reply 9, ECF No. 63.)

The Court again concludes that Lead Plaintiffs’ allegations could plausibly establish 

loss causation. See Gilead Scis., 536 F.3d at 1057; see also Lloyd v. CVB Fin. Corp., 811 

F.3d 1200, 1210 (9th Cir. 2016) (reversing district court’s holding that plaintiff had not 

adequately pled loss causation where defendant’s stock price dropped over 20% following 

announcement of SEC subpoena but “the market reacted hardly at all” to later disclosure 

revealing falsity of previous representations). Accordingly, the Court declines to grant 

Defendants’ MTD on this alternative ground at this time.

/ / /

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 19 of

 21
20

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

B. Section 20(a)

“Section 20(a) of the Act makes certain ‘controlling’ individuals also liable for 

violations of section 10(b) and its underlying regulations.” Zucco Partners, 552 F.3d at

990. Specifically, Section 20(a) provides:

Every person who, directly or indirectly, controls any person 

liable under any provision of this chapter or of any rule or 

regulation thereunder shall also be liable jointly and severally 

with and to the same extent as such controlled person to any 

person to whom such controlled person is liable (including to the 

Commission in any action brought under paragraph (1) or (3) of 

section 78u(d) of this title), unless the controlling person acted in 

good faith and did not directly or indirectly induce the act or acts 

constituting the violation or cause of action.

15 U.S.C. § 78t(a). “Thus, a defendant employee of a corporation who has violated the 

securities laws will be jointly and severally liable to the plaintiff, as long as the plaintiff 

demonstrates ‘a primary violation of federal securities law’ and that ‘the defendant 

exercised actual power or control over the primary violator.’” Zucco Partners, 552 F.3d at 

990 (quoting No. 84 Employer-Teamster Joint Council Pension Tr. Fund v. Am. W. 

Holding Corp., 320 F.3d 920, 945 (9th Cir. 2003)) (citing Paracor Fin., Inc. v. Gen. Elec. 

Capital Corp., 96 F.3d 1151, 1161 (9th Cir. 1996)). “Section 20(a) claims may be 

dismissed summarily . . . if a plaintiff fails to adequately plead a primary violation of 

section 10(b).” Id. (citing In re VeriFone Sec. Litig., 11 F.3d 865, 872 (9th Cir. 1993); In 

re Metawave Commc’ns Corp. Sec. Litig., 298 F. Supp. 2d 1056, 1087 (W.D. Wash. 2003)). 

Because the Court has dismissed Lead Plaintiffs’ cause of action predicated upon 

violations of Section 10(b), see supra Part II.A, the Court GRANTS Defendants’ MTD

and DISMISSES WITHOUT PREJUDICE Lead Plaintiffs’ second cause of action 

against the Individual Defendants for violations of Section 20(a).

/ / /

/ / /

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 20 of

 21
21

15-CV-408 JLS (DHB)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

CONCLUSION

In light of the foregoing, the Court GRANTS Defendants’ MTD (ECF No. 58).

While the Court entertains doubts concerning Lead Plaintiffs’ ability to adequately re-plead 

scienter, the Court will grant Lead Plaintiffs another opportunity to amend. Accordingly, 

the Court DISMISSES WITHOUT PREJUDICE Lead Plaintiffs’ SAC. (ECF No. 57.) 

Lead Plaintiffs MAY FILE a third amended complaint (TAC) within fourteen (14) days

of the date on which this Order is electronically docketed. Failure to file a TAC by this date 

may result in dismissal of this action with prejudice.

IT IS SO ORDERED.

Dated: April 5, 2017

Case 3:15-cv-00408-JLS-AGS Document 64 Filed 04/05/17 PageID.<pageID> Page 21 of

 21